Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-13T11:53:02.192Z Has data issue: false hasContentIssue false
  • English
  • Français

Systemic Lupus Erythematosus and Right Leg Weakness

Published online by Cambridge University Press:  02 December 2014

J. L. Steckley ,
M. C. Tartaglia ,
H. Reddy ,
S. Huang ,
R. Hammond  and
C. Hyson
J. L. Steckley*
Affiliation:
Department of Clinical Neurological Sciences, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada
M. C. Tartaglia
Affiliation:
Department of Clinical Neurological Sciences, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada
H. Reddy
Affiliation:
Department of Pathology, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada
S. Huang
Affiliation:
Department of Clinical Neurological Sciences, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada
R. Hammond
Affiliation:
Department of Pathology, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada
C. Hyson
Affiliation:
Department of Clinical Neurological Sciences, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada
*
Department of Clinical Neurological Sciences, LHSC-UH, 339 Windermere Road, London, Ontario, N6A 5A5, Canada.
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A 40-year old female presented to the emergency room at London Health Sciences Centre with a one week history of gradually progressive right leg weakness which had caused several falls. She also described numbness of the right arm and leg. In the two weeks leading up to admission she experienced gradually worsening shortness of breath, fatigue, anorexia, confusion, night sweats and somnolence. She also developed a herpetic rash of the right upper thigh which was treated with acyclovir and gabapentin.

Her past medical history was significant for a diagnosis of systemic lupus erythematosis (SLE) for seven years, treated at the time of admission with azathioprine 50 mg TID (several years duration), prednisone 5 mg BID, and hydroxyquine 400 mg daily. She also had a history of asthma and occasionally required Ventolin treatment. She had a 25 pack-year smoking history.

Type
Clinical Neuropathological Conference
Information
Canadian Journal of Neurological Sciences , Volume 36 , Issue 1 , January 2009 , pp. 98 - 101
Copyright
Copyright © The Canadian Journal of Neurological 2009

References

1.Joseph, FG, Lammie, GA, Scolding, NJ.CNS lupus. Neurology. 2007;69:644–54.CrossRefGoogle ScholarPubMed
2.The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608.Google Scholar
3.Bernatsky, S, Ramsey-Goldman, R, Rajan, R, Boivon, J-F, Joseph, L, Lachance, S, et al.Non-Hodgkin’s lymphoma in systemic lupus erythematosus. Ann Rheum Dis. 2005;64:1507–9.Google Scholar
4.Zintzaras, E, Voulgarelis, M, Moutsopoulos, HM.The risk of lymphoma development in autoimmune diseases. Arch Intern Med. 2005;165:2337–44.Google Scholar
5.Asten, P, Barrett, J, Symmons, D.Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases. J Rheumatol. 1999;26:1705–14.Google ScholarPubMed
6.Smith, JL, Wilkinson, AH, Hunsicker, LG, Tobacman, J, Kapelanski, DP, Johnson, M, et al.Increased frequency of post transplant lymphomas in patients treated with cyclosporine, azathioprine and prednisone. Transplant Proc. 1989;21(1 Pt 3):3199–200.Google Scholar
7.Kandiel, A, Fraser, AG, Korelitz, BI, Brensinger, C, Lewis, JD.Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005;54:1121–5.Google Scholar